Malignant Neoplasm of Stomach Recruiting Phase 3 Trials for Oxaliplatin (DB00526)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03221426Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants With Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-585/KEYNOTE-585)Treatment
NCT03399110XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)Prevention
NCT03745170Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric CancerTreatment
NCT02578368Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionTreatment
NCT03006705Study of Adjuvant ONO-4538 With Resected Gastric CancerTreatment
NCT03475615A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant AscitesTreatment
NCT01711242Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric CarcinomaTreatment
NCT02338518Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer PatientsTreatment
NCT02395640The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric CancerTreatment